Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
1.
Einstein (Säo Paulo) ; 13(4): 510-517, Oct.-Dec. 2015. tab, graf
Article in Portuguese | LILACS | ID: lil-770491

ABSTRACT

ABSTRACT Objective To determine the presence of glycosaminoglycans in the extracellular matrix of connective tissue from neoplastic and non-neoplastic colorectal tissues, since it has a central role in tumor development and progression. Methods Tissue samples from neoplastic and non-neoplastic colorectal tissues were obtained from 64 operated patients who had colorectal carcinoma with no distant metastases. Expressions of heparan sulphate, chondroitin sulphate, dermatan sulphate and their fragments were analyzed by electrospray ionization mass spectrometry, with the technique for extraction and quantification of glycosaminoglycans after proteolysis and electrophoresis. The statistical analysis included mean, standard deviation, and Student’st test. Results The glycosaminoglycans extracted from colorectal tissue showed three electrophoretic bands in agarose gel. Electrospray ionization mass spectrometry showed characteristic disaccharide fragments from glycosaminoglycans, indicating their structural characterization in the tissues analyzed. Some peaks in the electrospray ionization mass spectrometry were not characterized as fragments of sugars, indicating the presence of fragments of the protein structure of proteoglycans generated during the glycosaminoglycan purification. The average amount of chondroitin and dermatan increased in the neoplastic tissue compared to normal tissue (p=0.01). On the other hand, the average amount of heparan decreased in the neoplastic tissue compared to normal tissue (p= 0.03). Conclusion The method allowed the determination of the glycosaminoglycans structural profile in colorectal tissue from neoplastic and non-neoplastic colorectal tissue. Neoplastic tissues showed greater amounts of chondroitin sulphate and dermatan sulphate compared to non-neoplastic tissues, while heparan sulphate was decreased in neoplastic tissues.


RESUMO Objetivo Determinar a presença de glicosaminoglicanos na matriz extracelular do tecido conjuntivo colorretal neoplásico e não neoplásico, tendo em vista seu papel central no desenvolvimento e na progressão dos tumores. Métodos Amostras de tecidos colorretais neoplásicos e não neoplásicos foram obtidas de 64 pacientes operados com carcinoma colorretal sem metástases a distância. As expressões de heparan sulfato, sulfato de condroitina e sulfato de dermatan e seus fragmentos foram analisadas por espectrometria de massa por ionização por electrospray, com técnica de extração e quantificação de glicosaminoglicanos após proteólise e eletroforese. Para análise estatística, utilizaram-se média, desvio padrão e teste t de Student. Resultados Em gel de agarose, os glicosaminoglicanos extraídos de tecido colorretal mostraram três bandas eletroforéticas. A espectrometria de massa por ionização por electrospray mostrou fragmentos de dissacarídeos característicos de glicosaminoglicanos e indicou sua característica estrutural. Alguns picos na espectrometria de massa por ionização por electrospray não foram caracterizados como fragmentos de açúcares, sugerindo a presença de fragmentos de proteínas estruturais dos proteoglicanos, formadas durante a purificação dos glicosaminoglicanos. A quantidade média de condroitina e dermatan aumentou no tecido neoplástico em relação ao tecido normal (p=0,01). Por outro lado, a quantidade média de heparan foi menor no tecido neoplásico em relação ao tecido normal (p=0,03). Conclusão O método empregado permitiu determinar o perfil estrutural dos glicosaminoglicanos nas amostras. Tecidos neoplásicos apresentaram maiores quantidades de sulfato de condroitina e sulfato de dermatan em comparação com os não neoplásicos, enquanto o sulfato de heparan foi encontrado em menores quantidades nos tecidos neoplásicos.


Subject(s)
Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Carcinoma/chemistry , Colorectal Neoplasms/chemistry , Extracellular Matrix/chemistry , Glycomics/methods , Glycosaminoglycans/analysis , Carcinoma/pathology , Chondroitin Sulfates/analysis , Colorectal Neoplasms/pathology , Connective Tissue/chemistry , Disease Progression , Dermatan Sulfate/analysis , Electrophoresis, Polyacrylamide Gel , Heparitin Sulfate/analysis , Mucous Membrane/metabolism , Proteolysis , Spectrometry, Mass, Electrospray Ionization
2.
Rev. bras. ginecol. obstet ; 37(1): 5-9, 01/2015. tab
Article in English | LILACS | ID: lil-732871

ABSTRACT

PURPOSE: To describe maternal and neonatal outcomes in pregnant women undergoing hemodialysis in a referral center in Brazilian Southeast side. METHODS: Retrospective and descriptive study, with chart review of all pregnancies undergoing hemodialysis that were followed-up at an outpatient clinic of high- risk prenatal care in Southeast Brazil. RESULTS: Among the 16 women identified, 2 were excluded due to follow-up loss. In 14 women described, hypertension was the most frequent cause of chronic renal failure (half of cases). The majority (71.4%) had performed hemodialysis treatment for more than one year and all of them underwent 5 to 6 hemodialysis sessions per week. Eleven participants had chronic hypertension, 1 of which was also diabetic, and 6 of them were smokers. Regarding pregnancy complications, 1 of the hypertensive women developed malignant hypertension (with fetal growth restriction and preterm delivery at 29 weeks), 2 had acute pulmonary edema and 2 had abruption placenta. The mode of delivery was cesarean section in 9 women (64.3%). All neonates had Apgar score at five minutes above 7. CONCLUSIONS: To improve perinatal and maternal outcomes of women undergoing hemodialysis, it is important to ensure multidisciplinary approach in referral center, strict control of serum urea, hemoglobin and maternal blood pressure, as well as close monitoring of fetal well-being and maternal morbidities. Another important strategy is suitable guidance for contraception in these women. .


OBJETIVOS: Descrever os resultados maternos e neonatais de mulheres grávidas que estavam em tratamento de hemodiálise em um centro de referência no Sudeste brasileiro. MÉTODOS: Estudo retrospectivo e descritivo, com revisão de prontuários de todas as gestações em hemodiálise, acompanhadas no pré-natal especializado da região Sudeste do Brasil. RESULTADOS: Entre as 16 mulheres identificadas, 2 foram excluídas devido à perda de seguimento. Das 14 descritas, a hipertensão foi a causa mais frequente de insuficiência renal crônica (50% dos casos). A maioria (71,4%) realizava tratamento de hemodiálise há mais de um ano e todas elas foram submetidas a 5 ou 6 sessões por semana. Onze mulheres tinham hipertensão crônica, 1 das quais também era diabética, e 6 eram fumantes. Em relação às complicações da gravidez, 1 das mulheres hipertensas desenvolveu hipertensão maligna (com restrição de crescimento fetal e parto prematuro com 29 semanas), 2 tiveram edema pulmonar agudo e 2 apresentaram descolamento prematuro de placenta. O tipo de parto foi cesariana em 9 mulheres (64,3%). Todos os recém-nascidos tiveram Apgar aos cinco minutos maior que 7. CONCLUSÕES: Para melhorar os resultados perinatais e maternos de mulheres em hemodiálise, é importante ter uma abordagem multidisciplinar em centro de referência, um controle rigoroso da uremia, hemoglobina e pressão arterial materna, bem como acompanhar de perto o bem-estar fetal e a morbidade materna. Outra estratégia importante é a orientação adequada para contracepção nessas mulheres. .


Subject(s)
Aged , Female , Humans , Male , Middle Aged , Adenocarcinoma/drug therapy , Antineoplastic Agents/administration & dosage , Colorectal Neoplasms/drug therapy , Floxuridine/administration & dosage , Fluorouracil/metabolism , Pentosyltransferases/metabolism , Thymidylate Synthase/antagonists & inhibitors , Administration, Oral , Adenocarcinoma/chemistry , Adenocarcinoma/enzymology , Colorectal Neoplasms/chemistry , Colorectal Neoplasms/enzymology , Pyrimidine Phosphorylases
3.
Arq. gastroenterol ; 47(4): 361-367, Oct.-Dec. 2010. ilus, tab
Article in English | LILACS | ID: lil-570523

ABSTRACT

CONTEXT: NM23, a metastasis suppressor gene, may be associated with prognosis in patients with colorectal carcinoma. OBJECTIVE: To analyze NM23 expression and its association with the presence of lymph node and liver metastases and survival in patients operated on for colorectal carcinoma. METHODS: One hundred thirty patients operated on for colorectal carcinoma were investigated. Tissue microarray blocks containing neoplastic tissue and tumor-adjacent non-neoplastic mucosa were obtained and analyzed by immunohistochemical staining using a monoclonal anti-NM23 antibody. Immunohistochemical expression was assessed using a semiquantitative scoring method, counting the percentage of stained cells. The results were compared regarding morphological and histological characteristics of the colorectal carcinoma, presence of lymph node and liver metastases, tumor staging, and patient survival. Statistical analysis was performed using the Mann-Whitney test, the Kruskal-Wallis test and Fisher's exact test. Survival analysis was performed using the Kaplan-Meier method and the log-rank test. RESULTS: NM23 expression was higher in colorectal carcinoma tissue than in adjacent non-neoplastic mucosa (P<0.0001). NM23 protein expression did not correlate with degree of cell differentiation (P = 0.57), vascular invasion (P = 0.85), lymphatic invasion (P = 0.41), perineural infiltration (P = 0.46), staging (P = 0.19), lymph node metastases (P = 0.08), or liver metastases (P = 0.59). Disease-free survival showed significant association (P = 0.01) with the intensity of NM23 protein immunohistochemical expression in colorectal carcinoma tissue, whereas overall survival showed no association with NM23 protein expression (P = 0.13). CONCLUSIONS: NM23 protein expression was higher in neoplastic colorectal carcinoma tissue than in adjacent non-neoplastic mucosa, showing no correlation with morphological aspects, presence of lymph node or liver metastases, colorectal carcinoma staging, or overall survival. Disease-free survival was higher in patients with increased NM23 expression.


CONTEXTO: O NM23, denominado de gene supressor de metástases, pode estar relacionado com o prognóstico em doentes com carcinoma colorretal. OBJETIVOS: Analisar a expressão do marcador tumoral NM23 relacionando-a com a presença de metástases linfonodais e hepáticas e com a sobrevivência dos doentes operados por carcinoma colorretal. MÉTODO: Cento e trinta doentes operados por carcinoma colorretal foram analisados. Blocos de "tissue microarray" foram obtidos com tecido neoplásico e com mucosa não neoplásica adjacente ao tumor e submetidos ao estudo imunoistoquímico com o anticorpo monoclonal NM23. A imunoexpressão foi avaliada por método semiquantitativo, com contagem do percentual de células coradas. Os resultados encontrados foram relacionados com as características morfológicas e histopatológicas do carcinoma colorretal, presença de metástases linfonodais e hepáticas, estádio e sobrevivência dos doentes. O estudo estatístico foi realizado com os testes de Mann-Whitney, Kruskal-Wallis e exato de Fisher. A análise da sobrevivência foi calculada pelo método de Kaplan-Meier e pelo teste de long-rank. RESULTADOS: A expressão do marcador NM23 foi maior no tecido do carcinoma colorretal do que na mucosa não-neoplásica adjacente (P<0,0001). A expressão da proteína NM23 não apresentou relação com o grau de diferenciação celular (P = 0,57), invasão vascular (P = 0,85), invasão linfática (P = 0,41), infiltração perineural (P = 0,46), estádio (P = 0,19), metástases linfonodais (P = 0,08) ou metástases hepáticas (P = 0,59). A sobrevivência livre de doença mostrou relação significante (P = 0,01) com a intensidade de imunoexpressão da proteína NM23 no tecido do carcinoma colorretal, e a sobrevivência global não mostrou relação com a expressão da proteína NM23 (P = 0,13). CONCLUSÕES: A expressão da proteína NM23 foi mais intensa no tecido neoplásico do carcinoma colorretal do que na mucosa não-neoplásica adjacente. A expressão da proteína NM23 não se relacionou com os aspectos morfológicos, presença de metástases linfonodais ou hepáticas, estádio do carcinoma colorretal ou com a sobrevivência global. A sobrevivência livre de doença foi maior nos doentes com expressão aumentada do gene supressor de metástases NM23.


Subject(s)
Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Carcinoma/secondary , Colorectal Neoplasms/pathology , Liver Neoplasms/secondary , /analysis , Biomarkers, Tumor/analysis , Carcinoma/chemistry , Colorectal Neoplasms/chemistry , Colorectal Neoplasms/surgery , Disease-Free Survival , Immunohistochemistry , Intestinal Mucosa/chemistry , Lymphatic Metastasis , Lymph Nodes/enzymology , Microarray Analysis , Survival Analysis , Tissue Array Analysis
4.
Braz. j. med. biol. res ; 42(7): 593-598, July 2009. ilus, tab
Article in English | LILACS | ID: lil-517801

ABSTRACT

Blood and lymphatic vessel proliferation is essential for tumor growth and progression. Most colorectal carcinomas develop from adenomas (adenoma-carcinoma sequence) in a process due to accumulation of molecular genetic alterations. About 5% of adenomatous polyps are expected to become malignant, but data on the differential angiogenic patterns of these lesions in patients with and without concomitant cancer are missing. The aim of the present study is to compare the angiogenic and lymphatic patterns of adenomatous polyps from patients with and without sporadic cancer. Thirty adenomatous polyps (15 from patients with another principal malignant lesion, and 15 from patients without cancer) were submitted to immunohistochemical staining for CD105 (marker for neoangiogenesis) and D2-40 (marker for lymphatic endothelium). Microvessel density and total vascular area were determined by computer image analysis to quantify the immunostained and total areas, and to assess the number of microvessels. Adenomas from patients with carcinoma showed significantly higher values of total vascular area determined by immunostaining for CD105 (cutoff value = 4386 µm²; P = 0.019) and of lymphatic microvessel density determined by immunostaining with D2-40 (cutoff value = 11.5; P = 0.041) when compared with those from patients without cancer. The present data indicate a significant increase in blood microvascular area and in lymphatic microvascular counts in adenomas removed from patients with cancer.


Subject(s)
Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Adenomatous Polyps/pathology , Colorectal Neoplasms/pathology , Lymphangiogenesis/physiology , Neovascularization, Pathologic/pathology , Adenomatous Polyps/blood supply , Adenomatous Polyps/chemistry , Antibodies, Monoclonal/analysis , Antigens, CD/analysis , Biomarkers/analysis , Colorectal Neoplasms/blood supply , Colorectal Neoplasms/chemistry , Immunohistochemistry , Lymphatic Vessels/chemistry , Lymphatic Vessels/pathology , Microcirculation , Retrospective Studies , Receptors, Cell Surface/analysis
5.
Rev. Col. Bras. Cir ; 36(1): 56-64, jan.-fev. 2009. ilus, tab
Article in Portuguese | LILACS | ID: lil-514107

ABSTRACT

OBJETIVOS: Verificar a posssibilidade de quantificar a expressão dos marcadores tumorais CD-34 e Fator VIII no câncer de cólon; verificar se existe superioridade entre um marcador e outro para estudo da angiogênese; verificar se há correlação na análise do índice de marcagem e a densidade óptica média nos marcadores utilizados. MÉTODOS: Dezessete casos de adenocarcinoma colorretal recuperados de blocos de parafina e confirmados pela hematoxilina-eosina, foram submetidos à coloração imunoistoquímica pelo método da estreptoavidina-biotina-peroxidase e utilizados os marcadores tumorais CD-34 e Fator VIII. Após este processo as lâminas foram submetidas à leitura no sistema Samba 4000® e avaliadas pelo software Immuno®. Os parâmetros estudados foram: índice de marcagem e densidade óptica, expressos por médias, medianas, valores mínimos, valores máximos e desvios-padrão, analisados estatisticamente. RESULTADOS: Para o marcador CD-34 não houve normalidade dos dados em relação ao índice de marcagem e houve para a densidade óptica. Para o Fator VIII, houve normalidade de dados em relação ao índice de marcagem e para a densidade óptica. CONCLUSÃO: Foi possível quantificar a expressão dos marcadores tumorais CD-34 e Fator VIII através do índice de marcagem e da densidade óptica média; não houve diferença entre os marcadores em relação à média do índice de marcagem e da densidade óptica, não sendo possível definir superioridade entre um e outro; não foi observada tendência à correlação quando comparados densidade óptica e índice de marcagem do Fator VIII e do CD-34 isoladamente estudados; não houve correlação entre o índice de marcagem do Fator VIII quando comparado com o CD-34, bem como a densidade óptica do Fator VIII com o CD-34.


OBJECTIVES: In colorectal cancer, to describe the cytophotometric expression of the CD-34 and Factor VIII; to evaluate the degree of correlation between them; and to compare the CD-34 and Factor VIII expressions in relationship to label index and optical density. METHODS: Seventeen cases of colorectal adenocarcinoma recovered from paraffin-embedded archival tissue and confirmed by hematoxilin-eosin staining, were submitted to streptavidin-biotin-peroxidase immunohistochemical method. In this process was used the tumor markers CD-34 and Factor VIII. The obtained slides were analysed using the SAMBA 4000® system with Immuno® software. The results were evaluated into two parameters: label index and optical density, and expressed by averages, medians, minimum values, maximum values, and standard deviation values. The normality condition of the quantitative variables was investigated by using the Shapiro-Wilks test. In order to evaluate the degree of association between the expressions of the markers, Pearson's Correlation Coefficient or Spearman's Correlation Coefficient were applied. To evaluate the comparison degree of the markers expression, Student's t test or Wilcoxon's no parametric test were used. RESULTS: For the CD-34 there was no data normality for the label index and there was normality in the optical density. For the Factor VIII, there was data normality for the label index and for the optical density. CONCLUSION: When the expressions of CD-34 and Factor VIII markers were correlated, there was no difference between them in relationship to the average label index and average optical density. When the expressions of the CD-34 and Factor VIII were compared, there was no correlation between the two variables.


Subject(s)
Humans , Adenocarcinoma/metabolism , /biosynthesis , Colorectal Neoplasms/metabolism , Factor VIII/biosynthesis , Biomarkers, Tumor/biosynthesis , Adenocarcinoma/chemistry , /analysis , Cytophotometry , Colorectal Neoplasms/chemistry , Factor VIII/chemistry , Biomarkers, Tumor/analysis
6.
GED gastroenterol. endosc. dig ; 25(2): 33-36, mar-abr. 2006. graf, tab
Article in Portuguese | LILACS | ID: lil-502166

ABSTRACT

Objetivo: Analisar a ploidia do DNA em adenomas colorretais a fim de identificar a presença de aneuploidia como sendo um marcador de malignidade. Métodos: Trata-se de estudo transversal, prospectivo, realizado no Serviço de Endoscopia Digestiva do Hospital Geral da Universidade de Caxias do Sul, durante o período de junho de 2002 a 2004. Foram incluídos os pólipos adenomatosos de 22 pacientes submetidos a exames colonoscópicos. As variáveis estudadas foram: sexo, idade, tamanho do pólipo, tipo histopatológico e grau de displasia. Resultados: Alterações na ploidia do DNAforam vistas em 13 casos (59,09%). Todos os pacientes com displasia acentuada (n = 3) tinham estudo da ploidia de seu DNAanormal (p = 0,01). Em77,77% dos pólipos com displasia moderada (n = 7) verificou-se aneuploidia (p < 0,05). Emrelação ao diâmetro dos adenomas, verificou-se correlação positiva com a ocorrência de aneuploidia (p = 0,001). A comparação entre tipo histológico e aneuploidia não foi significativa.Conclusão: Adeterminação da aneuploidia tem sua utilidade como marcador biológico do potencial oncogênico dos adenomas colorretais. No presente estudo, em concordância com a literatura, a relação entre grau de displasia, diâmetro do adenoma e aneuploidia foi estatisticamente significativa.


Subject(s)
Humans , Adenoma , DNA, Neoplasm/analysis , Colorectal Neoplasms/chemistry , Ploidies , Aneuploidy , Colonoscopy , Cross-Sectional Studies , Flow Cytometry , Image Cytometry , Biomarkers
7.
The Korean Journal of Gastroenterology ; : 350-356, 2006.
Article in Korean | WPRIM | ID: wpr-56755

ABSTRACT

BACKGROUND/AIMS: De novo colorectal carcinoma shows more aggressive behavior including submucosal invasiveness. Both p53 and cyclo-oxygenase-2 (COX-2) have been shown to be involved in colon carcinogenesis, progression from adenoma to carcinoma, and submucosal invasion by tumor. We performed this study to evaluate the expression of p53 and COX-2 protein in de novo carcinoma, compared with ex-adenoma carcinoma. METHODS: Twenty three flat adenomas, 19 ex-adenoma carcinomas, 6 de novo carcinomas were included in this study. The expression of p53, COX-2 and Ki-67 were examined immunohistochemically. RESULTS: Both ex- adenoma carcinomas and de novo carcinomas showed similar size and shape. Positive staining for p53 was detected in 3 of 23 (13%) flat adenomas, in 11 of 19 (57.8%) ex-adenoma carcinomas (p<0.05), and in 1 of 6 (16.6%) de novo carcinomas. Increased numbers of COX-2 positive tumor cells were observed in 1 of 23 (4.3%) flat adenomas, in 2 of 19 (10.5%) ex-adenoma carcinomas, and in 3 of 6 (50%) de novo carcinomas. COX-2 positive expression showed increased tendency in de novo carcinoma (p=0.073). There was no correlation between COX-2, p53, and Ki-67 expression. CONCLUSION: De novo carcinoma shows increased tendency of COX-2 expression, but decreased p53 expression when compared to ex-adenoma carcinoma. These immunohistochemical findings are in accordance with the fact that de novo carcinoma has no preceding adenoma, with more frequent submucosal invasion despite the small lesion size.


Subject(s)
Female , Humans , Male , Middle Aged , Adenoma/chemistry , Carcinoma/chemistry , Colorectal Neoplasms/chemistry , Cyclooxygenase 2/analysis , Immunohistochemistry , Ki-67 Antigen/analysis , Biomarkers, Tumor/analysis , Tumor Suppressor Protein p53/analysis
8.
Acta cir. bras ; 20(6): 422-427, nov.-dez. 2005. graf
Article in English | LILACS | ID: lil-417055

ABSTRACT

OBJETIVO: Avaliação da expressão tumoral das proteínas c-erbB-2 e E-caderina e sua relação com o prognóstico, estadiamento e grau de diferenciação celular, em doentes com câncer colo-retal . MÉTODOS: O estudo incluiu 117 doentes com média de idade de 63.1 anos e com acompanhamento médio de 28.1 meses. O intervalo livre de doença, sobrevida, índice de recidiva e mortalidade específica foram os parâmetros avaliados. Anticorpos anti-oncoproteína c-erbB-2 (Dako) foram utilizados pela técnica da estreptavidiva-biotina. Considerou-se como positiva a presença desta proteína quando mais de 10% das células tumorais estivessem coradas. A proteína E-caderina foi estudada pelo anticorpo anti-E-caderina (Dako), sendo computada como positiva a amostra que apresentasse 50% ou mais das células coradas. A análise estatística utilizou o teste do qui-quadrado de Pearson, o teste exato de Fischer, a curva de Kaplan-Meier, o teste de log-rank e o teste de Wilcoxon ( variante de Breslow),sendo estabelecido nível de significância de 5%( p<0,05). RESULTADOS: 52 de 108 doentes estudados para c-erbB-2 foram positivos (48,1%), 47 de 93 doentes estudados para E-caderina foram negativos (50,5%). Estes dados não mostraram relação com estadiamento TNM (tumor, nódulo e metástase), com o grau de diferenciação celular e índice de recidiva tumoral. O intervalo livre de doença para os doentes positivos para c-erbB-2 e negativos para E-caderina foi de 68.0 meses e não diferiu daqueles que foram negativos para c-erbB-2 e positivos para E-caderina ( 55.0 meses - p = 0.5510). A sobrevida média para os doentes positivos para c-erbB-2 e negativos para E-caderina foi 75 meses sem diferença estatisticamente significante com o outro grupo de comparação( 61 meses - p = 0.5256). A mortalidade específica foi de 20.0% dos casos e não se correlacionou com a expressão do c-erbB-2 (p=0,446) ou da E-caderina(p=0,883). CONCLUSÃO: A expressão das proteínas c-erbB-2 e E-caderina em doentes portadores de adenocarcinoma colo-retal não apresentou correlação com o estadiamento e grau de diferenciação celular. Não houve da mesma forma relação com o prognóstico, no que diz respeito ao índice de recidiva da doença, intervalo livre de doença, sobrevida e mortalidade específica.


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Aged, 80 and over , Adenocarcinoma/pathology , Cadherins/analysis , Colorectal Neoplasms/pathology , Neoplasm Proteins/analysis , /analysis , Adenocarcinoma/chemistry , Adenocarcinoma/mortality , Antibodies, Monoclonal/immunology , Brazil/epidemiology , Epidemiologic Methods , Neoplasm Staging , Colorectal Neoplasms/chemistry , Colorectal Neoplasms/mortality , Prognosis
9.
The Korean Journal of Gastroenterology ; : 314-320, 2004.
Article in English | WPRIM | ID: wpr-92186

ABSTRACT

BACKGROUND/AIMS: Carcinogenesis is characterized by the abnormal regulation of cell cycle. The abnormal expression of the regulators of cell cycle may be related to the prognosis. Since the clinical significance of the expression of the three proteins in colorectal carcinomas is still controversial, we evaluated the prognostic value of the expression of cyclin E, p27 and mutant p53 in stage II colorectal cancer. METHODS: The expression levels of cyclin E, p27 and mutant p53 proteins in 41 patients with stage II colorectal carcinomas were analyzed by immunohistochemistry. RESULTS: In the univariate analysis, the level of CEA at diagnosis was associated with disease relapse. In the multivariate analysis, the clinicopathological variables such as age, gender, site of primary tumor, tumor size, state of tumor differentiation and preoperative plasma CEA level were not associated with disease relapse. When Kaplan-Meier survival curves were constructed to determine the prognosis, cyclin E, p27 and mutant p53 expressions did not predict poor prognosis. CONCLUSIONS: Our results suggested that the expression of cyclin E, p27 and mutant p53 proteins did not predict the clinical outcome in the stage II colorectal carcinomas.


Subject(s)
Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Adenocarcinoma/chemistry , Cell Cycle Proteins/analysis , Colorectal Neoplasms/chemistry , Cyclin E/analysis , Disease-Free Survival , Immunohistochemistry , Mutation , Prognosis , Tumor Suppressor Protein p53/analysis , Survival Rate , Biomarkers, Tumor/analysis , Tumor Suppressor Proteins/analysis
10.
Yonsei Medical Journal ; : 187-192, 2004.
Article in English | WPRIM | ID: wpr-51763

ABSTRACT

The proliferation potentials and the level of apoptosis were compared in paired primary colorectal adenocarcinomas and their liver metastases within each individual. From a total of 22 patients 44 specimens of paired primary and metastatic tumors were obtained for analysis. The levels of spontaneous apoptosis (a spontaneous apoptosis index, SAI: % apoptotic nuclei among a total of 1000 nuclei) and of proliferation (KI-67 index: % positively stained cells for KI-67 among a total of 1000 cells) were analyzed between primary and metastatic tumors. Survival rates and its relationship with the clinical parameters were also analyzed. The overall survival rate at 5 years was 16.9% with the median survival time of 45 months. T-stage (p=0.005) and time to liver metastasis (synchronous versus metachronous, p=0.03) showed statistical significance in relation to survival. The mean SAI of primary tumors was 1.35 +/- 0.25, which was not statistically different from the 1.58 +/- 0.18 of metastatic tumors (p=0.33). The mean KI-67 indices in primary and metastatic tumors were 23.9 +/- 3.4 and 16.4 +/- 2.5, respectively, and this difference was statistically significant (p=0.016). Subset analysis showed significant difference in the KI-67 index in the synchronous group but not in the metachronous group. No significant difference was shown in the relative ratios of apoptosis to proliferation between the primary tumor and the metastasis within each individual. The results in this study may partly explain the indolent behavior of liver metastasis from colorectal cancer and provides a rationale for the active treatment of metastatic tumors as well as of primary disease.


Subject(s)
Adult , Aged , Female , Humans , Male , Middle Aged , Adenocarcinoma/chemistry , Apoptosis , Cell Division , Colorectal Neoplasms/chemistry , Liver Neoplasms/chemistry
11.
Acta gastroenterol. latinoam ; 31(1): 7-11, mar. 2001. ilus, tab
Article in Spanish | LILACS | ID: lil-286827

ABSTRACT

El presente estudio refiere a una nueva herramienta que permite detectar fechaciente y tempranamente la naturaleza maligna del epitelio colorrectal. El objetivo es determinar una característica biológica diferente entre tejido normal y neo-plásico, como es el nivel de expresión del glicoepitope T (Ag Thomsen-Friedenreich). Se lo caracterizó en una serie de 62 muestras del tejido en estudio, incluyendo 31 normales (sin lesiones anatomopatológicas) y 31 correspondientes a cánceres (en su mayoría moderada o pobremente diferenciados). La expresíon del glicoconjugado se demostró por tectínhistoquímica, usando lectina PNA. Los patrones de unión de lectina fueron determinados en células absortivas (cilídricas) y caliciformes, normales y neoplásicas, encontrándose patrones característicos y diferentes según tipo de célula y naturaleza del tejido. El análisis estadístico de la localización citoestructural del Ag T en ambas poblaciones sugiere fuertemente que existe asociación entre el patrón de expresión y el grado de diferenciación tisular. La sencillez de la metodología hace a la determinación aplicable en diagnóstico de rutina y además tiene importante valor pronóstico.


Subject(s)
Humans , Male , Female , Middle Aged , Antigens, Tumor-Associated, Carbohydrate/analysis , Carcinoma/pathology , Colorectal Neoplasms/pathology , Epithelial Cells/chemistry , Lectins/analysis , Antigens, Tumor-Associated, Carbohydrate/immunology , Carcinoma/chemistry , Carcinoma/immunology , Colorectal Neoplasms/chemistry , Colorectal Neoplasms/immunology , Epithelial Cells/immunology , Immunohistochemistry
12.
Rev. bras. colo-proctol ; 18(1): 52-7, jan.-mar. 1998. ilus, tab
Article in Portuguese | LILACS | ID: lil-219919

ABSTRACT

A fisiopatologia da Doença de Chagas ainda näo está completamente esclarecida. O óxido nítrico (NO) tem sido citado como neurotransmissor responsável pelo relaxamento do esfíncter interno do ânus no indivíduo normal. Neuronal nicotinamida adenina dinucleotídeo fosfato (NADPH) diaforase pode ser usado como marcador neuronal do NO. Objetivos: Examinar as alteraçöes nos neurônios produtores de NO do cólon de pacientes submetidos à ressecçäo por megacólon avançado e comparar com o intestino delgado dos mesmos pacientes e com controles. Métodos: Espécimes obtidos da ressecçäo do reto e biópsias extramucosas do intestino delgado de 11 pacientes chagásicos foram comparadas a 10 pacientes controles com câncer de cólon. Os tecidos foram fixados em soluçäo de Zamboni e submetidos à histoquímica para neurônios contendo NADPH diaforase. A reatividade foi avaliada utilizando-se uma escala de 0 a 4 nas diversas camadas da parede intestinal: musculatura lisa longitudinal (ML), plexo mioentérico (PM), musculatura lisa circular (MC), plexo submucoso (PSM), e mucosa (M). Resultados: Os casos controles mostraram os plexos mioentérico e submucoso bem corados e uma rica rede de terminaçöes nervosas nas camadas musculares. Os espécimes provenientes de doentes chagásicos revelaram uma diminuiçäo da reatividade e da coloraçäo em todas as camadas do intestino. De maneira geral, houve uma diminuiçäo estatisticamente significante nos neurônios contendo NADPH diaforase. O intestino delgado clinicamente näo envolvido também demonstrou diminuiçäo da reatividade, porém em menor grau. Conclusöes: A atividade da NADPH diaforase está diminuída em pacientes com megacólon avançado, especialmente no plexo mioentérico e na camada muscular lisa; 2. Houve também uma diminuiçäo da atividade neuronal do NO no jejuno clinicamente näo envolvido pela doença, mas em menor grau


Subject(s)
Humans , Male , Female , Adolescent , Adult , Middle Aged , Chagas Disease/physiopathology , Immunohistochemistry , Intestine, Large/physiopathology , Megacolon/physiopathology , Megacolon/surgery , NADPH Dehydrogenase/analysis , NADPH Dehydrogenase/metabolism , Nitric Oxide Synthase/analysis , Nitric Oxide/analysis , Enteric Nervous System/physiopathology , Colorectal Neoplasms/chemistry , Chagas Disease/enzymology , Hirschsprung Disease/physiopathology , Fissure in Ano/drug therapy , Intestine, Large/enzymology , Intestine, Large/surgery , Intestine, Small/chemistry , Intestine, Small/enzymology , Megacolon/enzymology , Nitric Oxide Synthase/metabolism , Nitroglycerin/therapeutic use , Peristalsis , Enteric Nervous System/enzymology , Enteric Nervous System/chemistry , Vasodilator Agents/therapeutic use
13.
Asian Pac J Allergy Immunol ; 1993 Dec; 11(2): 119-22
Article in English | IMSEAR | ID: sea-37172

ABSTRACT

An immunohistochemical study was performed with 130 primary malignant human tumors of breast (n = 55)..colon/rectum (n = 16), stomach (n = 19), esophagus (n = 14), lung (n = 15) and liver (n = 11) using the 21N c-erbB-2 specific monoclonal antibody to identify the tumors that over-expressed the c-erbB-2 oncoprotein. Positivity appeared as an intense brown granular staining located predominantly at the cell membrane. This occurred in 41.8% of breast carcinomas, 12.5% of colorectal adenocarcinomas. None of the gastric adenocarcinomas, squamous cell carcinomas of the esophagus, small cell lung carcinomas or hepatocellular carcinomas were positive for the oncoprotein. The result of this study suggests that over-expression of the c-erbB-2 oncoprotein is common in breast cancer and relatively rare in other malignancies examined.


Subject(s)
Antibodies, Monoclonal , Breast Neoplasms/chemistry , Colorectal Neoplasms/chemistry , Female , Humans , Immunoenzyme Techniques , Neoplasms/chemistry , Proto-Oncogene Proteins/analysis , ErbB Receptors/analysis , Receptor, ErbB-2 , Biomarkers, Tumor/analysis
14.
Braz. j. med. biol. res ; 26(3): 277-84, Mar. 1993. tab
Article in English | LILACS | ID: lil-148692

ABSTRACT

1. Twenty-two colorectal carcinomas were examined for the presence of estrogen (ER), progesterone (PR), androgen (AR) and glucocorticoid receptors (GR) by a charcoal dextran assay. 2. ER was detected in 4/13 (31 per cent ) and 5/9 (56 per cent ) of the rectum and colon carcinomas analyzed, and density values ranged from 10 to 14 and from 10 to 27 fm/mg protein, respectively. Normal distal or adjacent mucosa presented similar incidence and ER density values within the tumor ranges. 3. The incidence of PR-positive samples was also higher in colon than in rectal carcinomas (44 per cent vs 23 per cent ). Normal mucosa displayed significantly higher PR titers than the corresponding tumor tissue. It seems reasonable to assume that normal colorectal mucosa may be one of the target tissues of progesterone activity. Most tumor biopsies and normal mucosa were completely AR negative, whilst GR was present in a larger fraction (63 per cent ) of tumoral specimens, occurring more commonly in colon than in rectum carcinomas. GR incidence tended to be higher in neoplasms than in normal mucosa (54 per cent vs 38 per cent in rectum and 78 per cent vs 56 per cent in colon), suggesting that glucocorticoids may be involved in the control of tumor-cell proliferation. 4. Our findings which indicate low densities of ER, PR, and absence of AR in some large bowel cancers, suggest sex hormone and endocrine independence for those cancers. The role of glucocorticoid receptors in those forms of cancer remains to be elucidated


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Colorectal Neoplasms/chemistry , Receptors, Steroid/analysis , Brazil , Receptors, Androgen , Receptors, Estrogen , Receptors, Glucocorticoid/analysis , Receptors, Progesterone/analysis
SELECTION OF CITATIONS
SEARCH DETAIL